Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study Article

TONG, X, ENGEHAUSEN, D, SHINE, D et al. (1998). Toxicity reduction of adenovirus mediated thymidine kinase gene therapy for ovarian cancer and subsequent combination with topoisomerase inhibitors: Design of a clinical phase I study . REPRODUCTIVE SCIENCES, 5(1), 47a-47a. 10.1016/s1071-5576(97)86111-4

cited authors

  • TONG, X; ENGEHAUSEN, D; SHINE, D; AGOULNIK, I; KIM, T; OEHLER, M; GUO, Y; HASENBURG, A; WOO, S; KIEBACK, D

authors

publication date

  • January 1, 1998

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 5.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Biotechnology
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Gene Therapy
  • Genetics
  • Orphan Drug
  • Ovarian Cancer
  • Rare Diseases
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • Springer Nature

start page

  • 47a

end page

  • 47a

volume

  • 5

issue

  • 1